U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H19BN2O3
Molecular Weight 214.07
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TALABOSTAT

SMILES

CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O

InChI

InChIKey=FKCMADOPPWWGNZ-YUMQZZPRSA-N
InChI=1S/C9H19BN2O3/c1-6(2)8(11)9(13)12-5-3-4-7(12)10(14)15/h6-8,14-15H,3-5,11H2,1-2H3/t7-,8-/m0/s1

HIDE SMILES / InChI

Molecular Formula C9H19BN2O3
Molecular Weight 214.07
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 16:01:11 UTC 2023
Edited
by admin
on Fri Dec 15 16:01:11 UTC 2023
Record UNII
KZ1O2SH88Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TALABOSTAT
INN   USAN  
USAN   INN  
Official Name English
TALABOSTAT [USAN]
Common Name English
talabostat [INN]
Common Name English
[(2R)-1-[(2S)-2-Amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid
Systematic Name English
BORONIC ACID, ((2R)-1-((2S)-2-AMINO-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C783
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
FDA ORPHAN DRUG 559416
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
FDA ORPHAN DRUG 697119
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
FDA ORPHAN DRUG 796720
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
FDA ORPHAN DRUG 559616
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
Code System Code Type Description
EPA CompTox
DTXSID70869984
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
PRIMARY
USAN
QQ-61
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
PRIMARY
FDA UNII
KZ1O2SH88Z
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
PRIMARY
MESH
C514044
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
PRIMARY
PUBCHEM
6918572
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
PRIMARY
SMS_ID
300000003720
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
PRIMARY
NCI_THESAURUS
C48264
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
PRIMARY
INN
8566
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
PRIMARY
DRUG BANK
DB06182
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
PRIMARY
ChEMBL
CHEMBL67279
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
PRIMARY
CAS
149682-77-9
Created by admin on Fri Dec 15 16:01:11 UTC 2023 , Edited by admin on Fri Dec 15 16:01:11 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY